Ampersand Biosciences awarded SBIR Grant for Immunologic Analysis of Non-Mammalian and Underrpresented Mammalian Models

Ampersand Biosciences was awarded a contract by the National Institute of Allergy and Infectious Diseases (NIAID) on September 20, 2022 until Dece,ber 15, 2024 for immunologic analysis of non-mammalian and underrepresented mammalian models.

NAICS: 541714 – Research and Development in Biotechnology (except Nanobiotechnology)
PSC: AN12 – Health R&D Services; Health Care Services; Applied Research